CN108308493A - A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing - Google Patents
A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing Download PDFInfo
- Publication number
- CN108308493A CN108308493A CN201810074321.4A CN201810074321A CN108308493A CN 108308493 A CN108308493 A CN 108308493A CN 201810074321 A CN201810074321 A CN 201810074321A CN 108308493 A CN108308493 A CN 108308493A
- Authority
- CN
- China
- Prior art keywords
- parts
- astaxanthin
- amino acid
- branched
- chain amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 40
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 40
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 40
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 40
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 40
- 235000013361 beverage Nutrition 0.000 title claims abstract description 18
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 17
- 239000007787 solid Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 150000005693 branched-chain amino acids Chemical class 0.000 claims abstract description 28
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000004475 Arginine Substances 0.000 claims abstract description 15
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 108010011485 Aspartame Proteins 0.000 claims abstract description 14
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 14
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 14
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 14
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 14
- 229960003438 aspartame Drugs 0.000 claims abstract description 14
- 239000000605 aspartame Substances 0.000 claims abstract description 14
- 235000010357 aspartame Nutrition 0.000 claims abstract description 14
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960002675 xylitol Drugs 0.000 claims abstract description 14
- 239000000811 xylitol Substances 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 14
- 235000010447 xylitol Nutrition 0.000 claims abstract description 14
- 229960003080 taurine Drugs 0.000 claims abstract description 13
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 8
- 229960003121 arginine Drugs 0.000 claims abstract description 7
- 235000009697 arginine Nutrition 0.000 claims abstract description 7
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 claims abstract description 5
- 229940024606 amino acid Drugs 0.000 claims description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 7
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 7
- 230000003179 granulation Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 6
- 239000004474 valine Substances 0.000 claims description 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 5
- 229960000310 isoleucine Drugs 0.000 claims description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 3
- -1 branched-amino Acid Substances 0.000 claims description 2
- 239000003094 microcapsule Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000002932 luster Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000009182 swimming Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000005550 wet granulation Methods 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 206010056720 Muscle mass Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a kind of anti-fatigue solid beverage of astaxanthin-containing and preparation method, which be mixed with by maltodextrin, branched-chain amino acid, arginine, xylitol, Aspartame, taurine, astaxanthin.Each component is by mass parts：30 50 parts of maltodextrin, 5 10 parts of branched-chain amino acid, 0.1 10 parts of arginine, 15 parts of xylitol; 0.1 3 parts of Aspartame, 0.001 0.05 parts of taurine, 0.1 5 parts of astaxanthin; wherein, leucine, isoleucine and valine, weight ratio 2 are contained in branched-chain amino acid:1:1.It is acted synergistically by antifatigue component, which can be effectively relieved exercise induced fatigue, reduce DOMS.Product good mouthfeel of the present invention, color and luster is scarlet, and raw material is suitble to sport and body-building crowd's daily consumption based on pure natural.
Description
Technical field
The invention belongs to food technology fields, and in particular to a kind of anti-fatigue solid beverage of astaxanthin-containing and preparation side
Method.
Background technology
Astaxanthin belongs to keto-acid carotenoid, is a kind of terpenes unsaturated compounds, 3,3 '-dihydroxy of chemical name
4,4 '-diketo-β, β '-carrotene of base-, molecular formula are：C40H52O4, have it is fat-soluble, it is not soluble in water.Due to its tool
The conjugated double bond chain molecular structure for having unsaturated ketone group and hydroxyl can provide the unpaired electron for attracting free radical, to remove
Free radical plays significant anti-oxidation efficacy.Astaxanthin is that separation and Extraction obtains from the shell of shrimp crab earliest, 80 years 20th century
The physiological active functions in generation, astaxanthin are protecting the skin from light injury, prevention of arterial hardening and related disease by extensive concern
Disease, active anticancer, enhance function of immune system, safeguard eyes and the health of central nervous system, strengthen body energetic supersession,
Anti-infection activity etc. all shows significant effect.Therefore, astaxanthin is in high-grade nutrient health care product, medical product, makeup
There is vast market prospect in the fields such as product, food additives.
When body movement, muscle can discharge free radical, if these free radicals will produce not by antioxidant timely processing
Raw oxidative pressure, causes the damage of DOMS or musculature.Studies have shown that astaxanthin can be used as a kind of antioxidant to press down
Free radical processed acts on the oxidative damage of body.In addition, oral astaxanthin can also strengthen aerobic metabolism, increase muscle strength and
Muscle tolerance alleviates rapidly sports fatigue, mitigates the Delayed onset myalgia generated after strenuous exercise.
Branched-chain amino acid is the neutral amino acid containing branch on a kind of α-carbon, therefore also referred to as BCAA, including leucine, different
Leucine and valine.Branched-chain amino acid belongs to essential amino acid, is mainly metabolized in skeletal muscle, accounts for about skeletal muscle protein
Essential amino acid 35%, the synthesis with skeletal muscle has substantial connection, be muscle formed necessary amino acid, can be carried for muscle
For energy, it can also promote muscle synthesis by Humoral immunity, muscle group can also be protected, prevent muscle mass.In addition, branched-amino
Acid can also inhibit tryptophan in blood to enter brain, and then reduce the synthesis of intracerebral serotonin, can alleviate tired spirit
Equal central nerve fatigues behavior.
Arginine is one of nonessential amino acid, is capable of the growth of stimulating growth hormone, therefore either child or big
People is required for it.Arginine not only facilitates body and generates muscle masses, may also help in treatment male fertility problem.
Invention content
The object of the present invention is to provide a kind of antifatigue solid beverage of astaxanthin-containing, which strengthens branched-chain amino acid
The effect of alleviating muscular fatigue is more suitable for moving personage's use.
It is a further object of the present invention to provide the preparation methods of the antifatigue solid beverage of above-mentioned astaxanthin-containing.
For realization foregoing invention target, the technical solution adopted by the present invention is：
A kind of anti-fatigue solid beverage of astaxanthin-containing, the solid beverage are by maltodextrin, branched-chain amino acid, smart ammonia
Acid, xylitol, Aspartame, taurine, astaxanthin are mixed with.The weight composition of each ingredient is as follows：Maltodextrin 30-
50 parts, 5-10 parts of branched-chain amino acid, 0.1-10 parts of arginine, 1-5 parts of xylitol, 0.1-3 parts of Aspartame, taurine 0.001-
0.05 part, 0.1-5 parts of astaxanthin.Wherein, leucine, isoleucine and valine, weight ratio 2 are contained in branched-chain amino acid:
1:1。
It is preferred that the weight composition of each ingredient is as follows：30-40 parts of maltodextrin, 8-10 parts of branched-chain amino acid, arginine 5-10
Part, 2-3 parts of xylitol, 0.1-0.5 parts of Aspartame, 0.01-0.02 parts of taurine, 0.1-1 parts of astaxanthin.Wherein, branch ammonia
Contain leucine, isoleucine and valine, weight ratio 2 in base acid:1:1.
The branched-chain amino acid is instant branched-chain amino acid, and preparation method is leucine, isoleucine, valine according to weight
Ratio 2:1:It is formed again by microcapsule embedded with the phosphatide for accounting for gross weight 0.5%-1.5% after 1 mixing.Specially by leucine,
Isoleucine, valine are according to weight ratio 2:1:1 mixing after be added material total weight 0.5%-1.5% phospholipid solution after
It is continuous to be sufficiently mixed uniformly, instant branched-chain amino acid is obtained after wet granulation, fluidized drying.
The preparation method of the anti-fatigue solid beverage of above-mentioned astaxanthin-containing should include following steps：
1) maltodextrin, arginine, xylitol, Aspartame, taurine are sufficiently mixed in proportion uniformly, using wet method
Granulation dries after the granulation of 80 mesh screens and obtains siccative, spare；
2) siccative and branched-chain amino acid for weighing astaxanthin and step 1) preparation are sufficiently mixed uniformly.
The present invention has the following advantages compared with other products：
Astaxanthin and branched-chain amino acid are used in combination the present invention, while supplementing amino acid energy, further alleviate
Fatigue enhances antioxidation, promotes to restore, generates synergistic effect；In addition, red is presented after being dissolved in water in astaxanthin, beverage is fresh
It is popular in bright, no longer needs to add other pigments and in good taste, free from extraneous odour, product eats healthier, is that body building, outdoor travel are first
Choosing.
Specific implementation mode
It is further illustrated the present invention below by way of specific embodiment.But the detail of embodiment is only used for explaining this hair
It is bright, it should not be construed as limited overall technical solution.Astaxanthin employed in following embodiment is purchased from Shaanxi
Sen Fu natural products Co., Ltd, product specification 2%.
Embodiment 1：
30 parts of maltodextrin, 10 parts of branched-chain amino acid, 6 parts of arginine, 2.5 parts of xylitol, 0.5 part of Aspartame, ox sulphur
0.011 part of acid, 0.5 part of astaxanthin (2% astaxanthin powder is purchased from Shaanxi Sen Fu natural products Co., Ltd).
1) by leucine：Isoleucine：Valine is according to weight ratio 2:1:After 1 is sufficiently mixed, material total weight is added
The phospholipid solution of 0.5%-1.5% continue to be sufficiently mixed uniformly, instant branch ammonia is obtained after wet granulation, fluidized drying
Base acid (also referred to as branched-chain amino acid), it is spare；
2) maltodextrin, arginine, xylitol, Aspartame, taurine are sufficiently mixed in proportion uniformly, using wet method
Granulation dries after the granulation of 80 mesh screens and obtains siccative, spare；
3) branched-chain amino acid prepared by the astaxanthin for weighing corresponding amount and the siccative and step 1) of step 2) preparation is fully mixed
Close uniform, bag distribution packaging.Obtained beverage is dissolved in scarlet bright after water, drinks in good taste.
Embodiment 2：
33 parts of maltodextrin, 10 parts of branched-chain amino acid, 5 parts of arginine, 2 parts of xylitol, 0.3 part of Aspartame, taurine
0.011 part, 0.5 part of astaxanthin.
1) by leucine：Isoleucine：Valine is according to weight ratio 2:1:After 1 is sufficiently mixed, material total weight is added
The phospholipid solution of 0.5%-1.5% continue to be sufficiently mixed uniformly, instant branch ammonia is obtained after wet granulation, fluidized drying
Base acid (also referred to as branched-chain amino acid), it is spare；
2) maltodextrin, arginine, xylitol, Aspartame, taurine are sufficiently mixed in proportion uniformly, using wet method
Granulation dries after the granulation of 80 mesh screens and obtains siccative, spare；
3) weigh the siccative that the astaxanthin of corresponding amount is prepared with step 2) and branched-chain amino acid prepared by step 1) according to than
Example be sufficiently mixed uniformly, bag distribution packaging.Obtained beverage is dissolved in scarlet bright after water, drinks in good taste.
3 anti-fatigue test of embodiment
Using 1 product of embodiment as sample, antifatigue effect verification is carried out.Take male mouse of kunming 30, weight 18-
22g is randomly divided into 4 groups by weight, every group 10, carries out swimming with a load attached to the body experiment.
Blank group：The preparation method is the same as that of Example 1, but unbranched amino acid and astaxanthin in formula, remaining dispensing is the same as implementation
Example 1, it is 3g to take 1 deal, purify after water dissolution with 20-30mL, and gavage is carried out by 1mL/ pcs/day；
Experimental group 1：The preparation method is the same as that of Example 1, but without astaxanthin in formula, and takes 15 deal branched-chain amino acids, remaining
For dispensing with embodiment 1, it is 3g to take 1 deal, purify after water dissolution with 20-30mL, gavage is carried out by 1mL/ pcs/day；
Experimental group 2：The preparation method is the same as that of Example 1, but unbranched amino acid in formula, and takes 1 parts by weight astaxanthin powder,
For remaining dispensing with embodiment 1, it is 3g to take 1 deal, purify after water dissolution with 20-30mL, gavage is carried out by 1mL/ pcs/day；
Experimental group 3：It is 3g to take 1 deal of sample being prepared according to 1 method of embodiment, purifies water dissolution with 20-30mL
Afterwards, by 1mL/ pcs/day of progress gavage.
Mouse adaptability grow 1 week after according to the oral gavage of test dose, continuous 30 days, last gave given the test agent
Swimming with a load attached to the body experiment, record swimming swimming time are carried out after 30min.Experimental result is shown in Table 1.
Influence of 1 composition of table to mouse swimming time
| Group | Walking weight load/min |
| Blank group | 15.4±1.5 |
| Experimental group 1 | 19.7±2.1 |
| Experimental group 2 | 18.4±2.4 |
| Experimental group 3 | 26.6±2.8 |
From table 1 it follows that the swimming time of product of the present invention is above blank and control experiment group, illustrate this
The each component of invention product has synergistic effect, can play good antifatigue effect.
Claims (5)
1. a kind of anti-fatigue solid beverage of astaxanthin-containing, it is characterised in that the solid beverage is by maltodextrin, branched-amino
Acid, arginine, xylitol, Aspartame, taurine, astaxanthin are mixed with.
2. the anti-fatigue solid beverage of astaxanthin-containing according to claim 1, it is characterised in that the weight of each ingredient forms
It is as follows：
30-50 parts of maltodextrin, 5-10 parts of branched-chain amino acid, 0.1-10 parts of arginine, 1-5 parts of xylitol, Aspartame 0.1-3
Part, 0.001-0.05 parts of taurine, 0.1-5 parts of astaxanthin.
Wherein, leucine, isoleucine and valine, weight ratio 2 are contained in branched-chain amino acid:1:1.
3. the anti-fatigue solid beverage of astaxanthin-containing according to claim 2, it is characterised in that the weight of each ingredient forms
It is as follows：
30-40 parts of maltodextrin, 8-10 parts of branched-chain amino acid, 5-10 parts of arginine, 2-3 parts of xylitol, Aspartame 0.1-0.5
Part, 0.01-0.02 parts of taurine, 0.1-1 parts of astaxanthin.
Wherein, leucine, isoleucine and valine, weight ratio 2 are contained in branched-chain amino acid:1:1.
4. the anti-fatigue solid beverage of astaxanthin-containing according to claim 1,2 or 3, it is characterised in that branched-chain amino acid is
Leucine, isoleucine, valine and phosphatide are formed by microcapsule embedded, and phosphatide additive amount is 0.5%-1.5%.
5. the preparation method of the anti-fatigue solid beverage of astaxanthin-containing as claimed in claim 1,2 or 3, it is characterised in that this method
Including following steps：
1) maltodextrin, arginine, xylitol, Aspartame, taurine are sufficiently mixed in proportion uniformly, using wet method system
Grain dries after the granulation of 80 mesh screens and obtains siccative, spare；
2) siccative and branched-chain amino acid for weighing astaxanthin and step 1) preparation are sufficiently mixed uniformly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810074321.4A CN108308493A (en) | 2018-01-25 | 2018-01-25 | A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810074321.4A CN108308493A (en) | 2018-01-25 | 2018-01-25 | A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108308493A true CN108308493A (en) | 2018-07-24 |
Family
ID=62887914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810074321.4A Pending CN108308493A (en) | 2018-01-25 | 2018-01-25 | A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108308493A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109247574A (en) * | 2018-11-26 | 2019-01-22 | 青岛浩然生物科技有限公司 | A kind of production method of natural astaxanthin and nostoc compound powder |
| CN109588618A (en) * | 2018-12-13 | 2019-04-09 | 新疆阜丰生物科技有限公司 | A method of BCAA particle is produced using fluidized bed drying technology |
| CN110477377A (en) * | 2019-08-02 | 2019-11-22 | 大连医诺生物股份有限公司 | The molten type of the mouth of the ingredient containing non-fat-soluble directly drinks powder and preparation method thereof |
| CN110876440A (en) * | 2019-11-26 | 2020-03-13 | 睿藻生物科技（苏州）有限公司 | Astaxanthin effervescent tablet for improving athletic ability and preparation method thereof |
| CN111972584A (en) * | 2020-07-13 | 2020-11-24 | 荣成市森维迪生物科技有限公司 | Astaxanthin-containing anti-aging solid beverage |
| CN112515070A (en) * | 2020-11-11 | 2021-03-19 | 云南爱尔康生物技术有限公司 | Sports beverage containing astaxanthin, taurine, nicotinamide mononucleotide and electrolyte and preparation method thereof |
| CN112715874A (en) * | 2020-12-10 | 2021-04-30 | 浙江蓝美生物技术有限公司 | Blueberry powder compound solid preparation for resisting fatigue and improving sexual dysfunction as well as preparation method and application thereof |
| CN113475661A (en) * | 2021-07-07 | 2021-10-08 | 攀枝花学院 | Multifunctional body-building instant solid beverage and preparation method thereof |
| CN115363159A (en) * | 2021-01-04 | 2022-11-22 | 云南爱尔发生物技术股份有限公司 | Astaxanthin anti-fatigue solid beverage |
| CN115363154A (en) * | 2021-01-04 | 2022-11-22 | 云南爱尔发生物技术股份有限公司 | Astaxanthin anti-fatigue sports drink |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101484158A (en) * | 2006-07-05 | 2009-07-15 | 花王株式会社 | Senescence inhibitor |
| CN102813753A (en) * | 2012-05-22 | 2012-12-12 | 孟令刚 | Composition containing Cistanche deserticola or Herba Cynomorii and combination of chrysanthemum, taurine, lycopene, xanthophyll and beta-carotene |
| CN104666327A (en) * | 2015-01-14 | 2015-06-03 | 中国海洋大学 | Application of low-polymer mannuronic acid and derivative thereof in preparation of medicines and health products for resisting fatigue and amyotrophia |
| CN105193842A (en) * | 2015-11-05 | 2015-12-30 | 阿士力(深圳)运动健康科技有限公司 | Effervescent tablets capable of supplementing antioxidant and application of effervescent tablets |
| CN105558744A (en) * | 2015-12-19 | 2016-05-11 | 江苏神华药业有限公司 | Effervescent tablets containing branched chain amino acid and preparation method of effervescent tablets |
| CN105831537A (en) * | 2016-04-05 | 2016-08-10 | 杭州鑫伟低碳技术研发有限公司 | Preparation method of anti-fatigue astaxanthin |
| CN106135907A (en) * | 2015-04-11 | 2016-11-23 | 青岛贝尔特生物科技有限公司 | A kind of alimentation composition contributing to resisting fatigue |
| CN107432440A (en) * | 2017-07-27 | 2017-12-05 | 云南德彩堂生物医药科技有限公司 | A kind of composition for significantly improving anti-fatigue effect and its preparation method and application |
-
2018
- 2018-01-25 CN CN201810074321.4A patent/CN108308493A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101484158A (en) * | 2006-07-05 | 2009-07-15 | 花王株式会社 | Senescence inhibitor |
| CN102813753A (en) * | 2012-05-22 | 2012-12-12 | 孟令刚 | Composition containing Cistanche deserticola or Herba Cynomorii and combination of chrysanthemum, taurine, lycopene, xanthophyll and beta-carotene |
| CN104666327A (en) * | 2015-01-14 | 2015-06-03 | 中国海洋大学 | Application of low-polymer mannuronic acid and derivative thereof in preparation of medicines and health products for resisting fatigue and amyotrophia |
| CN106135907A (en) * | 2015-04-11 | 2016-11-23 | 青岛贝尔特生物科技有限公司 | A kind of alimentation composition contributing to resisting fatigue |
| CN105193842A (en) * | 2015-11-05 | 2015-12-30 | 阿士力(深圳)运动健康科技有限公司 | Effervescent tablets capable of supplementing antioxidant and application of effervescent tablets |
| CN105558744A (en) * | 2015-12-19 | 2016-05-11 | 江苏神华药业有限公司 | Effervescent tablets containing branched chain amino acid and preparation method of effervescent tablets |
| CN105831537A (en) * | 2016-04-05 | 2016-08-10 | 杭州鑫伟低碳技术研发有限公司 | Preparation method of anti-fatigue astaxanthin |
| CN107432440A (en) * | 2017-07-27 | 2017-12-05 | 云南德彩堂生物医药科技有限公司 | A kind of composition for significantly improving anti-fatigue effect and its preparation method and application |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109247574A (en) * | 2018-11-26 | 2019-01-22 | 青岛浩然生物科技有限公司 | A kind of production method of natural astaxanthin and nostoc compound powder |
| CN109588618A (en) * | 2018-12-13 | 2019-04-09 | 新疆阜丰生物科技有限公司 | A method of BCAA particle is produced using fluidized bed drying technology |
| CN109588618B (en) * | 2018-12-13 | 2022-08-26 | 新疆阜丰生物科技有限公司 | Method for producing BCAA granules by fluidized bed drying technology |
| CN110477377A (en) * | 2019-08-02 | 2019-11-22 | 大连医诺生物股份有限公司 | The molten type of the mouth of the ingredient containing non-fat-soluble directly drinks powder and preparation method thereof |
| CN110876440A (en) * | 2019-11-26 | 2020-03-13 | 睿藻生物科技（苏州）有限公司 | Astaxanthin effervescent tablet for improving athletic ability and preparation method thereof |
| CN111972584A (en) * | 2020-07-13 | 2020-11-24 | 荣成市森维迪生物科技有限公司 | Astaxanthin-containing anti-aging solid beverage |
| CN112515070A (en) * | 2020-11-11 | 2021-03-19 | 云南爱尔康生物技术有限公司 | Sports beverage containing astaxanthin, taurine, nicotinamide mononucleotide and electrolyte and preparation method thereof |
| CN112715874A (en) * | 2020-12-10 | 2021-04-30 | 浙江蓝美生物技术有限公司 | Blueberry powder compound solid preparation for resisting fatigue and improving sexual dysfunction as well as preparation method and application thereof |
| CN115363159A (en) * | 2021-01-04 | 2022-11-22 | 云南爱尔发生物技术股份有限公司 | Astaxanthin anti-fatigue solid beverage |
| CN115363154A (en) * | 2021-01-04 | 2022-11-22 | 云南爱尔发生物技术股份有限公司 | Astaxanthin anti-fatigue sports drink |
| CN113475661A (en) * | 2021-07-07 | 2021-10-08 | 攀枝花学院 | Multifunctional body-building instant solid beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108308493A (en) | A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing | |
| EP2941261B1 (en) | Synergistic curcuma and cissus compositions for enhancing physical performance and energy levels | |
| CN101742999B (en) | Anti-fatigue agent and oral composition each comprising and rographolide as active ingredient | |
| JP2000247878A (en) | Theanine-containing composition | |
| CN109329902A (en) | A kind of leukemia of children tailored version clinical nutrition formula and preparation method thereof | |
| AT513274B1 (en) | Dietary supplements | |
| RU2609813C1 (en) | Functional food product "amino jam" | |
| US6159476A (en) | Herbal supplement for increased muscle strength and endurance for athletes | |
| US20100015259A1 (en) | Composition and method for improving human concentration, memory and other cognitive brain | |
| DE102008064588A1 (en) | Nutritional supplement based on pantothenic acid | |
| JP2003304845A (en) | Drink or food | |
| CN114916631A (en) | Ultrahigh-purity octacosanol-flavone composite deuterium-depleted water combined and co-refined high-energy beverage and preparation method thereof | |
| CN107439866A (en) | Matrimony vine chickpea plant nutrients beverage and its preparation technology | |
| JPH0549444A (en) | Food for improvement of stamina | |
| CN106616980B (en) | Composition for promoting muscle synthesis after strength training and preparation method thereof | |
| RU2156086C1 (en) | Method of using biologically active food additions in diet of sportsmen nutrition | |
| JP2003304846A (en) | Drink or food | |
| DE202018101715U1 (en) | Agent for the treatment of neurodegenerative diseases | |
| DE102014118772B4 (en) | Dietary supplement in capsule form containing Chinese medicinal mushrooms and their use | |
| RU2579215C1 (en) | Dry mixture for beverage preparation | |
| CN107811254A (en) | A kind of low fat mellowness mushroom soup stock | |
| EP0920321A1 (en) | Vitamine preparations for reducing oxygen consumption during physical efforts | |
| CN108450761A (en) | A kind of nutrient powder and preparation method thereof that benefiting qi and nourishing blood enhancing is immune | |
| RU2323599C1 (en) | Biologically active food additive and its production method | |
| Szabo | Real and Legal Nutritional Alternative (eg Application of Free Amino Acids) to Replace Forbidden Doping Substances to Produce Excellent Sport Performance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180724 |